ResearchMoz

China Human Vaccine Industry Report, 2010-2011

Publisher Name » Research In China
Published Date » 2011-05-11
No. Of Pages » 82

With the improvement of economy and peoples disease prevention awareness, Chinas human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market scale in 2010 hit RMB10.3 billion, up 14.4% year-on-year.

Under the influence of Chinas actual conditions and the vaccine industry characteristics, state-owned human vaccine enterprises take a lions share in the market, especially in the EPI (Expanded Program on Immunization) vaccines market. In terms of lot release quantity, state-owned enterprises occupied 68.1% of the extra EPI vaccines market in 2010. For example, meningococcal vaccines and hepatitis A vaccine are mainly offered by stated-owned enterprises including 6 research institutions under China National Biotec Group and Kunming Branch of Chinese Academy of Medical Science.

Granted, with the industry development, Chinas vaccine market is lowering its entry barrier and becoming more open. And private enterprises have become a new force in the extra EPI vaccines market, with market share soaring. Likewise, foreign enterprises are also major players in the extra EPI vaccines market by virtue of their technology and product advantages. In 2010, the market share of private enterprises and foreign enterprises in the extra EPI vaccines market marked 39.8% and 15.5% by lot release quantity respectively.

Taking HIB vaccine market for example, the market share of private enterprises and foreign ones in 2010 combined to 59.9% by lot release quantity. But in the pneumonia vaccines market, foreign enterprises including Sanofi Pasteur and Wyeth took up 49.6% by lot release quantity in 2010.

Although domestic enterprises have taken the leading position in the EPI vaccines market, they are going into overdrive to develop the highly profitable extra EPI vaccines market and have made some achievements. A case in point is Sinovac Biotech Co., Ltd., which is conducting clinical trial for its 13-valence pneumonia vaccine; on December 24th, 2010, the 71-type inactivated vaccine for hand-foot-month disease and enterovirus developed by China National Biotec Group was approved by the State Food and Drug Administration for clinical study.

Moreover, domestic vaccine enterprises have scored significant achievement in the R&D of therapeutic vaccines. For example, Chongqing Brewery has made smooth progress in the clinical trial of synthetic peptide hepatitis b vaccine. As of Feb. 2011, 101 subjects had finished 76-week-long phase II b clinical trial of the vaccine. Changchun High & New Technology Industries Group, the only listed company of China engaged in the R&D of AIDS vaccine, started the phase I clinical trial for its therapeutic AIDS vaccine in March 2011.
Table Of Content

1. Overview of Vaccine Industry
1.1 Definition & Classification
1.2 Industry Chain

2. China Human Vaccine Industry & Market
2.1 Overview
2.2 Operating Environment
2.2.1 International Market
2.2.2 Policy Environment
2.2.3 Biopharmaceutical Market in China
2.3. Status Quo
2.4 Supply & Demand
2.5 Competition Pattern
2.6 Dynamics

3. Human Vaccine Market Segments in China
3.1 Hepatitis B Vaccine
3.1.1 Supply & Demand
3.1.2 Competition Pattern
3.1.3 Market Price
3.2 Meningococcal Vaccines
3.2.1 Supply & Demand
3.2.2 Competition Pattern
3.2.3 Market Price
3.2.4 Market Forecast
3.3 Hepatitis A Vaccine
3.3.1 Supply & Demand
3.3.2 Competition Pattern
3.3.3 Market Price
3.3.4 Market Forecast
3.4 Influenza Vaccine
3.4.1 Supply & Demand
3.4.2 Competition Pattern
3.4.3 Market Price
3.5 Hib Vaccine
3.5.1 Supply & Demand
3.5.2 Competition Pattern
3.5.3 Market Price
3.5.4 Market Forecast
3.6 Rabies Vaccine
3.6.1 Supply & Demand
3.6.2 Competition Pattern
3.6.3 Market Price
3.6.4 Dynamics
3.6.5 Market Forecast
3.7 Varicella Vaccine
3.7.1 Supply & Demand
3.7.2 Competition Pattern
3.7.3 Market Price
3.8 Pneumococcal Vaccines
3.8.1 Supply & Demand
3.8.2 Competition Pattern
3.8.3 Market Price

4. Chinas Import and Export of Vaccines in 2010-2011
4.1 Human Vaccines
4.1.1 Import
4.1.2 Export

5. Major Vaccine Manufacturers in China
5.1 China National Biotec Group
5.1.1 Beijing Tiantan Biological Products Co., Ltd
5.1.2 Shanghai Institute of Biological Products
5.2 Hualan Biological Engineering Inc.
5.2.1 Operation
5.2.2 Operation of Vaccine Business
5.2.3 Prospect of Vaccine Business
5.3 Liaoning Chengda Biotechnology Co., Ltd
5.3.1 Operation
5.3.2 Operation of Vaccine Business
5.3.3 Prospect of Vaccine Business
5.4 Chongqing Zhifei Biological Products Co., Ltd
5.4.1 Profile
5.4.2 Operation
5.4.3 Development Plan
5.5 Walvax Biotechnology Co., Ltd
5.5.1 Profile
5.5.2 Operation
5.5.3 Vaccine Projects
5.6 Sinovac Biotech Ltd.
5.6.1 Profile
5.6.2 Development
5.7 Changchun Changsheng Life Sciences Limited
5.8 Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd
5.9 Shenzhen Kangtai Biological Products Co. Ltd
5.10 Dalian Hissen Bio-Pharm Co., Ltd
5.11 Neptunus
5.11.1 Operation
5.11.2 Vaccine Business & Development
5.12 Star Lake Bioscience
5.12.1 Operation
5.12.2 Vaccine Business & Development

List of Tables

NA

List of Figures

Animal Vaccine Types and Characteristics
Animal Vaccine Industry Chain
Amount of Livestock on Hand in China, 2005-2010
Classification of Animal Disease
Chinas GDP Growth Rate, 2007-2011Q2
Major Policies Related to Animal Vaccine Industry, As of 2010
Chinas Meat, Poultry & Egg and Milk Output, 2007-2010
Global Animal Vaccine Market Scale, 2004 & 2008-2010
Vaccine Sales of Global Top 5 Vaccine Manufacturers, 2007-2010
Main Mergers & Acquisitions in the Vaccine Industry Worldwide, 2005-Apr.2011
Market Size of Human Vaccine and Animal Vaccine in China, 2007-2010
EPI Vaccine Varieties in China, 2010
Gross Margin of Major Vaccine Manufacturers in China, 2007-2010
Mandatory Animal Disease Immunization Programs of China, 2009-2011
Chinas Animal Vaccine Market Share by Category, 2009-2010
Chinas Animal Vaccine Industry Market Scale & Growth, 2006-2010
Major Manufacturers of Animal Vaccines in China
Production of Chinas Key Animal Vaccine Manufacturers
Chinas Animal Vaccine Consumption Structure by Animal Species, 2009-2010
Chinas Animal Vaccination Program, 2011
Market Shares of Chinas Main Animal Vaccine Manufacturers by Sales, 2010
Manufacturers of Government Procurement Vaccines, 2008-2010
Compulsory Vaccination Products of Listed Animal Vaccine Companies, 2010
Chinas Animal Vaccine Export Volume, Value and Average Unit Price, 2007-2010
Chinas Animal Vaccine Oversea Market Distribution, 2010
Chinas Animal Vaccine Import Volume, Value and Average Unit Price, 2007-2010
Origins of Chinas Imported Animal Vaccines, 2010
Chinas Animal Vaccine Industry Development Driving Forces
M & A of Animal Vaccine Enterprises in China, by Aug 2011
Chinas Pig Inventory and Slaughter Quantity, 2000-2010
Chinas Pig Vaccine Market Scale, 2008-2010
Chinas Pet Vaccine Suppliers
Performance Comparison of Chinas Various Hog Cholera Vaccines
Designated FMD Vaccine Manufacturers and Their Market Shares, 2010
PRRS Vaccine Prices
Chinas Poultry Vaccine Market Scale, 2008-2010
Major Poultry Vaccine Varieties and Manufacturers in China
Market Capacity of Newcastle Disease Vaccine and Market Share of Tianjin Ringpu Bio-technology
Cattle & Sheep Vaccine Market Scale, 2008-2010
Chinas Pet Vaccine Market Scale, 2008-2010
Operating Revenue and Net Income of CAHIC, 2007-2011Q1
Operating Revenue & Structure by Business of CAHIC, 2007-2010
Operating Revenue of CAHIC by Region, 2008-2010
Animal Vaccine Capacity Distribution of CAHIC
Animal Vaccine Sales Volume by Category of CAHIC, 2007-2010
Animal Vaccine Operating Income and Gross Margin of CAHIC, 2007-2010
Operating Revenue and Net Income of Jinyu Group, 2007-2011Q1
Operating Revenue & Structure by Business of Jinyu Group, 2007-2010
Operating Income and Operating Margin of Jinyu Group, 2008-2010
Operating Revenue by Region of Jinyu Group, 2008-2010
Animal Vaccine Capacity Distribution of Jinyu Group
Animal Vaccine Revenue and Gross Margin of Jinyu Group, 2007-2010
R&D Advantages of Jinyu Group
Operating Revenue and Net Income of Tecon, 2007-2011Q1
Operating Revenue and Structure by Business of Tecon, 2007-2010
Operating Income and Operating Margin of Tecon, 2008-2010
Ratio of R&D Input to Operating Revenue of Tecon, 2007-2010
Operating Revenue by Region of Tecon, 2008-2010
Animal Vaccine Revenue and Gross Margin of Tecon, 2007-2010
Progress of Animal Vaccine R&D of Tecon, As of 2010
Operating Revenue and Net Income of Ningbo Tech-Bank, 2008-2011Q1
Operating Revenue and Structure by Business of Ningbo Tech-Bank, 2008-2010
Gross Margin by Product of Ningbo Tech-Bank, 2008-2010
Operating Revenue and Operating Income of Chengdu Tech-Bank, 2008-2010
Operating Revenue and Net Income of Shenghua Biok, 2007-2011Q1
Operating Revenue and Structure by Business of Shenghua Biok, 2007-2010
Operating Margin of Shenghua Biok, 2007-2010
Operating Revenue Structure of Shenghua Biok by Region, 2008-2010
Operating Revenue and Net Income of Yebio QD, 2008-2010
Operating Revenue and Net Income of Huasun Group, 2007-2011Q1
Operating Revenue and Structure by Business of Huasun Group, 2008-2010
Gross Margin by Business of Huasun Group, 2007-2010
Operating Revenue and Net Income of Sichuan Huasun, 2008-2010
Operation of Harbin Pharmaceutical Group, 2008-2009
Operating Revenue and Net Income of Tianjin Ringpu Bio-technology, 2008-2011H1
Sales of Tianjin Ringpu Bio-technology by Product, 2008-2010
Gross Margin of Tianjin Ringpu Bio-technology by Product, 2007-2010
Sales Revenue from Governmental Tendering and Its ratio of Tianjin Ringpu Bio-technology, 2008-2010
R & D Input and Its Ratio to Operating Revenue of Tianjin Ringpu Bio-technology, 2008-2010
Animal Vaccine Revenue of Tianjin Ringpu Bio-technology by Product, 2007-2010H1
Operating Revenue and Net Income of Guangdong Dahuanong Animal Health Products, 2008-2011Q1
Sales of Guangdong Dahuanong Animal Health Products by Product, 2008-2010
Gross Margin of Guangdong Dahuanong Animal Health Products by Product, 2007-2010
R & D Input and Its Ratio to Operating Revenue of Guangdong Dahuanong Animal Health Products, 2008-2010
Main Animal Vaccine Products of Guangdong Dahuanong Animal Health Products
Vaccine Projects under R&D and Their Progress of Dahuanong Animal Health Products, As of 2010
Animal Vaccine Products of Boehringer-Ingelheim in China Market, As of 2010

Upcoming Reports:

Synthetic and Bio-Based Butadiene Market: Industry Overview, Applications and Downstream Potential Opportunities, 2010 - 2018
By - Transparency Market Research
1,3-Butadiene, frequently referred to as butadiene, is a simple conjugated diene with the chemical formula C4H6. It is predominantly used as a monomer for producing synthetic rubber in industries. It is produced as a byproduct of the steam cracking used for producing ethylene and olefins; it is also produced from dehydrogenation of n-butane. The global demand of butadiene has been increasing as main application of butadiene is in the production of acrylonitrile butadiene styrene and styrene butadiene rubber which is basically used for manufacturing automotive tires....
Paper Thin Display (PTD) Market - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018
By - Transparency Market Research
Paper thin display (PTD) is a new generation ultra-thin display with a thickness smaller than 1.5 mm which is similar to a standard sheet of paper. These displays can be used for non-flat surface devices and can be easily wrapped on any electronic device. PTD finds a wide range of applications in electronic devices, signage used for advertising, and automotive display. The PTDs market has observed a significant growth in the last few years due to the increasing innovation in computers and mobile devices to develop smaller and thinner devices. The  market has observed a...
Energy Retrofits Systems Market - Global Industry Analysis, Market Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
The rising demand for energy and limited/inefficient storage systems are proving inadequate to satisfy the demand for industrial energy requirements. Researchers are aggressively and continuously working in order to develop and manufacture effective and efficient systems that will store and distribute the required amount of energy globally. Energy retrofits are the adjustment or addition to the existing energy consuming equipment that are utilized in commercial outlets and in buildings. The desire to reduce energy costs required to operate the industry is the primary driving...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...